Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaron Arbel

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Cardiology|July 3, 2018
Proton Pump Inhibitors and Dual Antiplatelet Therapy: Is the Story Over?Yaron Arbel
Heart (British Cardiac Society)|December 1, 2016
When will we learn that smoking is bad?Yaron Arbel
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|February 13, 2009
Large animal models for diastolic dysfunction and diastolic heart failure-a review of the literatureShay Dubi, Yaron Arbel
International Journal of Cardiology|December 24, 2011
Response to the letter: How to manage coronary slow flow following PCI?Yaron Arbel, Shmuel Banai
The Israel Medical Association Journal : IMAJ|February 17, 2021
Type II Diabetes Mellitus and Endothelial Dysfunction: What Can We Do?Ilan Merdler, Yaron Arbel
The Israel Medical Association Journal : IMAJ|June 30, 2005
Renin-angiotensin system inhibitors and atrial fibrillationYaron Arbel, Michael Glikson
Cardiology and Therapy|February 9, 2018
A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today?Yishay Szekely, Yaron Arbel
Cardiology|May 28, 2016
Low HbA1c Levels and Mortality: The Story Is Not Over Yet…Ofer Havakuk, Yaron Arbel
The Canadian Journal of Cardiology|October 3, 2015
suPAR: A Cardiac Biomarker With a Future?Yaron Arbel, Bradley H Strauss
European Heart Journal|September 4, 2015
Mortality benefits with CTO PCI: moving the goalpost closerYaron Arbel, Bradley H Strauss
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Cardiology|July 3, 2018
Proton Pump Inhibitors and Dual Antiplatelet Therapy: Is the Story Over?Yaron Arbel
Heart (British Cardiac Society)|December 1, 2016
When will we learn that smoking is bad?Yaron Arbel
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|February 13, 2009
Large animal models for diastolic dysfunction and diastolic heart failure-a review of the literatureShay Dubi, Yaron Arbel
International Journal of Cardiology|December 24, 2011
Response to the letter: How to manage coronary slow flow following PCI?Yaron Arbel, Shmuel Banai
The Israel Medical Association Journal : IMAJ|February 17, 2021
Type II Diabetes Mellitus and Endothelial Dysfunction: What Can We Do?Ilan Merdler, Yaron Arbel
The Israel Medical Association Journal : IMAJ|June 30, 2005
Renin-angiotensin system inhibitors and atrial fibrillationYaron Arbel, Michael Glikson
Cardiology and Therapy|February 9, 2018
A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today?Yishay Szekely, Yaron Arbel
Cardiology|May 28, 2016
Low HbA1c Levels and Mortality: The Story Is Not Over Yet…Ofer Havakuk, Yaron Arbel
The Canadian Journal of Cardiology|October 3, 2015
suPAR: A Cardiac Biomarker With a Future?Yaron Arbel, Bradley H Strauss
European Heart Journal|September 4, 2015
Mortality benefits with CTO PCI: moving the goalpost closerYaron Arbel, Bradley H Strauss
Pageof 20